Telix Book Value Per Share from 2010 to 2024

TLX Stock

15.76 0.16 1.03%

Telix Pharmaceuticals Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to -0.26 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Telix Pharmaceuticals Limited according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

(0.25)

Current Value

(0.26)

Quarterly Volatility

1.0920665

Credit Downgrade

Yuan Drop

Covid

Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 1.1 M, Depreciation And Amortization of 7.1 M or Interest Expense of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.41, Days Sales Outstanding of 45.23 or Average Payables of 1.8 M. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Telix Pharmaceuticals Correlation against competitors.

Latest Telix Pharmaceuticals' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Telix Pharmaceuticals Limited over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Telix Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.21 X

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Telix Book Value Per Share Regression Statistics

	Arithmetic Mean	(0.50)
	Geometric Mean	0.26
	Coefficient Of Variation	(219.40)
	Mean Deviation	0.63
	Median	(0.22)
	Standard Deviation	1.09
	Sample Variance	1.19
	Range	4.4434
	R-Value	0.03
	Mean Square Error	1.28
	R-Squared	0.0007
	Significance	0.93
	Slope	0.01
	Total Sum of Squares	16.70

Telix Book Value Per Share History

	2024	-0.26
	2023	-0.25
	2019	-0.22
	2018	-4.23
	2017	0.21
	2016	-0.16
	2015	-0.0187

Other Fundumenentals of Telix Pharmaceuticals

Tangible Book Value Per Share

Telix Pharmaceuticals Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Long Term Investments
Total Assets		0.78	0.87	-0.74	-0.78	0.93	0.86	0.95	0.73	0.94	0.81	0.9	0.98	0.95	0.23	0.87	0.91	0.95	-0.64
Total Stockholder Equity	0.78		0.47	-0.82	-0.25	0.5	0.37	0.55	0.37	0.51	1.0	0.61	0.79	0.58	0.67	0.78	0.73	0.58	-0.38
Current Deferred Revenue	0.87	0.47		-0.64	-0.94	0.92	0.9	0.93	0.82	0.93	0.52	0.95	0.84	0.92	-0.04	0.71	0.8	0.92	-0.88
Net Debt	-0.74	-0.82	-0.64		0.5	-0.49	-0.37	-0.57	-0.74	-0.57	-0.82	-0.83	-0.82	-0.68	-0.74	-0.52	-0.53	-0.68	0.57
Retained Earnings	-0.78	-0.25	-0.94	0.5		-0.89	-0.89	-0.9	-0.9	-0.92	-0.3	-0.89	-0.77	-0.92	0.14	-0.49	-0.62	-0.92	0.72
Accounts Payable	0.93	0.5	0.92	-0.49	-0.89		0.99	0.99	0.7	0.99	0.55	0.84	0.87	0.95	-0.14	0.81	0.89	0.95	-0.68
Long Term Debt	0.86	0.37	0.9	-0.37	-0.89	0.99		0.97	0.66	0.97	0.43	0.78	0.79	0.91	-0.29	0.76	0.85	0.91	-0.67
Net Receivables	0.95	0.55	0.93	-0.57	-0.9	0.99	0.97		0.77	1.0	0.6	0.89	0.92	0.98	-0.03	0.79	0.87	0.98	-0.66
Good Will	0.73	0.37	0.82	-0.74	-0.9	0.7	0.66	0.77		0.8	0.41	0.92	0.81	0.87	0.27	0.32	0.44	0.87	-0.58
Total Liab	0.94	0.51	0.93	-0.57	-0.92	0.99	0.97	1.0	0.8		0.56	0.89	0.91	0.98	-0.05	0.75	0.84	0.98	-0.67
Net Invested Capital	0.81	1.0	0.52	-0.82	-0.3	0.55	0.43	0.6	0.41	0.56		0.65	0.82	0.62	0.63	0.81	0.77	0.62	-0.41
Short Long Term Debt	0.9	0.61	0.95	-0.83	-0.89	0.84	0.78	0.89	0.92	0.89	0.65		0.92	0.93	0.26	0.65	0.73	0.93	-0.79
Total Current Assets	0.98	0.79	0.84	-0.82	-0.77	0.87	0.79	0.92	0.81	0.91	0.82	0.92		0.95	0.37	0.77	0.82	0.95	-0.59
Capital Stock	0.95	0.58	0.92	-0.68	-0.92	0.95	0.91	0.98	0.87	0.98	0.62	0.93	0.95		0.11	0.71	0.79	1.0	-0.64
Net Working Capital	0.23	0.67	-0.04	-0.74	0.14	-0.14	-0.29	-0.03	0.27	-0.05	0.63	0.26	0.37	0.11		0.06	0.0	0.11	0.07
Short Term Debt	0.87	0.78	0.71	-0.52	-0.49	0.81	0.76	0.79	0.32	0.75	0.81	0.65	0.77	0.71	0.06		0.99	0.71	-0.63
Intangible Assets	0.91	0.73	0.8	-0.53	-0.62	0.89	0.85	0.87	0.44	0.84	0.77	0.73	0.82	0.79	0.0	0.99		0.79	-0.69
Common Stock	0.95	0.58	0.92	-0.68	-0.92	0.95	0.91	0.98	0.87	0.98	0.62	0.93	0.95	1.0	0.11	0.71	0.79		-0.64
Long Term Investments	-0.64	-0.38	-0.88	0.57	0.72	-0.68	-0.67	-0.66	-0.58	-0.67	-0.41	-0.79	-0.59	-0.64	0.07	-0.63	-0.69	-0.64

Click cells to compare fundamentals

About Telix Pharmaceuticals Financial Statements

Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	(0.25)	(0.26)
Tangible Book Value Per Share	(0.36)	(0.37)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC